FHM VII, L.P.
Insider CIK 1654632 · ANAB 10% owner · IMGO 10% owner · ITRM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 64,360 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 225,850 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 740,673 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,199,890 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 211,069 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 341,932 | — | $0 | 0 | SEC↗ |
| IMGO Imago BioSciences, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 145,918 | $16.00 | $2.33M | 145,918 | SEC↗ |
| IMGO Imago BioSciences, Inc. | P Buy | 2021-07-20 | 2021-07-20 | 41,582 | $16.00 | $665.3K | 41,582 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 64,360 | — | $0 | 658,943 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 211,069 | — | $0 | 594,583 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 225,850 | — | $0 | 2,312,331 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 740,673 | — | $0 | 2,086,481 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 1,199,890 | — | $0 | 1,345,808 | SEC↗ |
| IMGO Imago BioSciences, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 341,932 | — | $0 | 383,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 1,167,000 | $1167000.00 | $1361.89B | 1,167,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 333,000 | $333000.00 | $110.89B | 333,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 141,166 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 495,370 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 44,940 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 53,899 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 157,701 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 189,141 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 53,899 | — | $0 | 195,065 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 141,166 | — | $0 | 141,166 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 157,701 | — | $0 | 842,212 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 189,141 | — | $0 | 684,511 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 495,370 | — | $0 | 495,370 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 44,940 | — | $0 | 240,005 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 101,150 | $13.00 | $1.31M | 341,155 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 354,949 | $13.00 | $4.61M | 1,197,161 | SEC↗ |
| ANAB ANAPTYSBIO INC | J Other | 2018-05-11 | 2018-05-15 | 1,372,000 | — | $0 | 973,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise deriv | 2017-02-02 | 2017-02-06 | 117,235 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise | 2017-02-02 | 2017-02-06 | 117,235 | $4.55 | $533.4K | 2,345,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 733,740 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 195,751 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 209,095 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 311,291 | $15.00 | $4.67M | 311,291 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 88,709 | $15.00 | $1.33M | 88,709 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 1,428,571 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 604,055 | SEC↗ |